Oscar Health (NYSE:OSCR) Shares Down 4.7%

Shares of Oscar Health, Inc. (NYSE:OSCR - Get Free Report) fell 4.7% during mid-day trading on Tuesday . The stock traded as low as $14.04 and last traded at $14.07. 457,295 shares changed hands during mid-day trading, a decline of 86% from the average session volume of 3,245,617 shares. The stock had previously closed at $14.77.

Wall Street Analyst Weigh In

Several research firms recently issued reports on OSCR. TheStreet raised shares of Oscar Health from a "d" rating to a "c-" rating in a research note on Wednesday, February 21st. The Goldman Sachs Group lifted their price objective on shares of Oscar Health from $8.00 to $16.00 and gave the company a "neutral" rating in a research note on Friday, February 9th. Raymond James began coverage on shares of Oscar Health in a research note on Friday, March 22nd. They issued an "outperform" rating and a $20.00 price objective for the company. Finally, Wells Fargo & Company lifted their price objective on shares of Oscar Health from $12.00 to $20.00 and gave the company an "overweight" rating in a research note on Thursday, February 15th. Two investment analysts have rated the stock with a hold rating and four have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus price target of $13.50.

Oscar Health Stock Performance

The stock has a market cap of $3.21 billion, a price-to-earnings ratio of -11.88 and a beta of 1.79. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.19 and a current ratio of 1.19. The stock's 50-day simple moving average is $15.04 and its two-hundred day simple moving average is $10.28.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its quarterly earnings data on Wednesday, February 7th. The company reported ($0.66) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.74) by $0.08. Oscar Health had a negative net margin of 4.62% and a negative return on equity of 29.99%. The company had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.43 billion. During the same quarter in the previous year, the firm posted ($1.05) EPS. The business's revenue was up 43.9% compared to the same quarter last year. Analysts forecast that Oscar Health, Inc. will post -0.23 earnings per share for the current year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the stock. Charles Schwab Investment Management Inc. increased its holdings in shares of Oscar Health by 19.3% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 1,125,355 shares of the company's stock worth $6,268,000 after purchasing an additional 182,206 shares during the period. Graham Capital Management L.P. bought a new stake in Oscar Health in the third quarter valued at about $894,000. Versor Investments LP bought a new stake in Oscar Health in the third quarter valued at about $553,000. Dark Forest Capital Management LP bought a new stake in Oscar Health in the third quarter valued at about $581,000. Finally, Algert Global LLC increased its stake in Oscar Health by 160.1% in the third quarter. Algert Global LLC now owns 147,567 shares of the company's stock valued at $822,000 after acquiring an additional 90,840 shares during the period. Institutional investors own 75.70% of the company's stock.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.